People · Operator
Named in public records as an officer, director or promoter · active 2013–2013 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Pharmetrics Specialty Group of Arkansas, LLC | — | Pharmaceuticals | Pre-Seed | $350K | $490K | — |
| Pharmetrics Specialty Group of Atlanta, LLC | — | Pharmaceuticals | Pre-Seed | $350K | $490K | — |
| Pharmetrics Specialty Group of Dallas, LLC | — | Pharmaceuticals | Pre-Seed | $350K | $490K | — |
| Pharmetrics Specialty Group of Houston, LLC | — | Pharmaceuticals | Pre-Seed | $350K | $490K | — |
| Pharmetrics Specialty Group of Mississippi, LLC | — | Pharmaceuticals | Pre-Seed | $350K | $490K | — |
| Pharmetrics Specialty Group of San Antonio, LLC | — | Pharmaceuticals | Pre-Seed | $350K | $490K | — |
| Psg Of Tampa Llc | — | Pharmaceuticals | Pre-Seed | $250K | $350K | — |
| Pharmetrics Specialty Group of Austin, LLC | — | Pharmaceuticals | Pre-Seed | $204K | $9.6M | 2013 |
| PSG of Orlando, LLC | — | Pharmaceuticals | Pre-Seed | $138K | $6.5M | 2013 |
| PSG of Sarasota, LLC | — | Pharmaceuticals | Pre-Seed | $114K | $5.4M | 2013 |
DEAN PEDALINO at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside DEAN PEDALINO on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| JACOB MICHEL | 10 | 12 |
| JOHN EADES | 10 | 11 |
| PETER DAY | 10 | 11 |
| DAN LAMAR | 9 | 9 |
| ROBERT STROUD | 9 | 9 |
| Ryan Myers | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.